Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125639221 | 12563922 | 1 | I | 201601 | 20160615 | 20160716 | 20160716 | PER | US-ASTRAZENECA-2016SE66510 | ASTRAZENECA | 728.00 | MON | F | Y | 74.40000 | KG | 20160716 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125639221 | 12563922 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 10 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 10 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 10 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 5 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 5 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 6 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 5 | MG | TABLET | QD | |||||||
| 125639221 | 12563922 | 7 | C | SOTALOL. | SOTALOL | 1 | Oral | 0 | 80 | MG | QD | ||||||||
| 125639221 | 12563922 | 8 | C | TRIBENZOR | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 0 | |||||||||||
| 125639221 | 12563922 | 9 | C | SLO-MAG | 2 | Oral | DAILY | 0 | |||||||||||
| 125639221 | 12563922 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | IU | QD | ||||||||
| 125639221 | 12563922 | 11 | C | VITAMIN B | VITAMIN B | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125639221 | 12563922 | 1 | Blood cholesterol increased |
| 125639221 | 12563922 | 2 | Blood triglycerides abnormal |
| 125639221 | 12563922 | 3 | Total cholesterol/HDL ratio abnormal |
| 125639221 | 12563922 | 4 | Blood cholesterol increased |
| 125639221 | 12563922 | 5 | Blood triglycerides abnormal |
| 125639221 | 12563922 | 6 | Total cholesterol/HDL ratio abnormal |
| 125639221 | 12563922 | 7 | Arrhythmia |
| 125639221 | 12563922 | 8 | Hypertension |
| 125639221 | 12563922 | 9 | Haemoglobin abnormal |
| 125639221 | 12563922 | 10 | Haemoglobin abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125639221 | 12563922 | Headache | |
| 125639221 | 12563922 | Intentional product misuse | |
| 125639221 | 12563922 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125639221 | 12563922 | 1 | 201601 | 201605 | 0 | |
| 125639221 | 12563922 | 2 | 201601 | 201605 | 0 | |
| 125639221 | 12563922 | 3 | 201601 | 201605 | 0 | |
| 125639221 | 12563922 | 4 | 201605 | 0 | ||
| 125639221 | 12563922 | 5 | 201605 | 0 | ||
| 125639221 | 12563922 | 6 | 201605 | 0 | ||
| 125639221 | 12563922 | 7 | 2008 | 0 | ||
| 125639221 | 12563922 | 8 | 2012 | 0 | ||
| 125639221 | 12563922 | 9 | 201605 | 0 | ||
| 125639221 | 12563922 | 10 | 201601 | 0 |